ORMP compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ORMPOramed Pharmaceuticals Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ORMPOramed Pharmaceuticals Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ORMP 0

None

Shared 0

No disclosed counterparties: ORMP.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR

ORMPOramed Pharmaceuticals Inc.

3.92▼−5.14%· post 3.92· delayed

Mkt cap$171.8MRevenue$2MQ1 FY25Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,357.85· delayed

After hoursNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 5 '26delayed

ORMPOramed Pharmaceuticals Inc.

LLYELI Lilly & Co

3.92▼−5.14%post 3.92delayed

Price

1,371.32▼−3.29%post 1,357.85delayed

$171.8M

Mkt cap

$1.3T

Q1 FY25$2M

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

ORMP3.92▼−5.14%vsLLY1,371.32▼−3.29%After hoursNov 5 '26delayed